ReviewFrontiers in robotics and AI2025
Nano bio-robots: a new frontier in targeted therapeutic delivery.
Review in Frontiers in robotics and AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In macro world, the robots are programmed machines, engineered to perform repetitive and often specialized tasks. Scaling down the size of a robot by a billionth of a meter gives a nano robot. The primary driving force behind the advent of micro and nano robots have always been the domain of medical technology and these robots are popularly known as nano bio-robots. The current review shines a light on these bio-robots in all their facets, encompassing both top-down and bottom-up fabrication approaches to their associated challenges followed by ethical approvals. The study describes in detail the synthesis techniques of nano bio-robot along with required actuation mechanism of the bio-robots. Further, in this paper, how a nano biorobotic drug-delivery system (NDDS) can deliver the drugs in a controlled way to the targeted site of the host in contrast to conventional drug administration is discussed. The paper also reviews and summarizes the administration pathways of these bio-robots in the human body and their efficacy in reducing various disorders. Overall, it can be said that the integration of nano robots with bio-concept presents distinct advantages and possesses significant promises for many applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.